Philips puts forth a buyout offer for Carestream’s HCIS business
Category: #health  By Paroma Bhattacharya  Date: 2019-03-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

Philips puts forth a buyout offer for Carestream’s HCIS business

Royal Philips, the Netherlands-based healthcare technology company, has reportedly entered into an agreement with Carestream Health, a healthcare IT solutions provider, in a bid to acquire its HCIS (Healthcare Information Systems) business.

Reportedly, following the latest acquisition, the expanded healthcare IT business of Philips will feature the enterprise imaging platform of Carestream, including best-in-class VNA, multimedia reporting, operational, clinical & business analytical tools, diagnostic & enterprise viewers and workflow orchestrator, as a part of its wide portfolio. Apparently, Philips, similar to Carestream, has developed a strong global business that is customer-focused and is based on continuous innovation and world-class technical excellence.

Carestream’s HCIS business unit, for the record, offers imaging IT solutions to imaging centers, multi-site hospitals, radiology service providers and specialty medical clinics across the globe. Moreover, the business has formed strong relationships with customers in the high-growth healthcare segments, which further positions it for consistent growth and success.

Robert Cascella, Chief Business Leader of Precision Diagnosis, Royal Philips, was quoted stating that the company collaborates with global healthcare providers in order to connect people, information & technology with a strong commitment to deliver improved health outcomes, better staff experiences, improved patient experience and lower healthcare costs. He added that the latest acquisition is expected to enhance the company’s potential to provide flexible solutions for hospitals and health systems.

Authentic sources revealed that Philip’s excellent combination of successful innovations in workflow optimization, AI-enabled informatics and imaging system platforms with the cloud-based platform for enterprise imaging informatics and complementary geographic footprint of Carestream, is likely to present a concrete foundation for delivering on the promise of precision diagnosis.

The deal is reportedly slated to be concluded by the second half of 2019, subject to regulatory approvals and customary closing conditions. Additional details of the transaction have not yet been disclosed.



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

MacroGenics, I-Mab team up to develop & market enoblituzumab in China
MacroGenics, I-Mab team up to develop & market enoblituzumab in China
By Paroma Bhattacharya

MacroGenics, Inc. and I-Mab Biopharma, a U.S. and China based clinical-stage biopharmaceutical company that is committed to discover and develop biologics in autoimmune and immune-oncology diseases, have recently announc...

ViiV Healthcare announces positive result in TANGO Phase 3 study
ViiV Healthcare announces positive result in TANGO Phase 3 study
By Paroma Bhattacharya

ViiV Healthcare Limited, a pharmaceutical company specializing in HIV treatment, recently announced positive results from Phase 3 TANGO study.

The study was conducted to assess vira...

Skyhawk Therapeutics expands licensing partnership with Biogen
Skyhawk Therapeutics expands licensing partnership with Biogen
By Paroma Bhattacharya

Skyhawk Therapeutics, Inc. has recently announced the expansion of its partnership with Biogen, which was initially announced on January 4, 2019.

The expansion, which leverages on the breadth of SkySTAR™ technology platform from Skyh...